Hypertension impairs myocardin function: A novel mechanism facilitating arterial remodelling

Cardiovascular Research

Volumn 96, Issue 1, 2012, Pages 120-129

  Pfisterer, Larissa ^a   Feldner, Anja ^a   Hecker, Markus ^a   Korff, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hypertension; Myocardin; Stretch; Vascular smooth muscle cells; Wall stress

Indexed keywords

CALPONIN; CYTOPLASM PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOCARDIN; PROTEASOME; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BIOMECHANICS; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; HEART CONTRACTION; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOFLUORESCENCE TEST; INTRACELLULAR TRANSPORT; MALE; MOUSE; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SMOOTH MUSCLE FIBER;

ANIMALS; ARTERIES; CALCIUM-BINDING PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOPLASM; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; PHENOTYPE; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 84866666844     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs247     Document Type: Article

References (40)

1. Haudenschild CC, Grunwald J, Chobanian AV. Effects of hypertension on migration and proliferation of smooth muscle in culture. Hypertension 1985;7:I101-I104.
2. Olivetti G, Melissari M, Marchetti G, Anversa P. Quantitative structural changes of the rat thoracic aorta in early spontaneous hypertension. Tissue composition, and hypertrophy and hyperplasia of smooth muscle cells. Circ Res 1982;51:19-26.
3. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-587.
4. Bohr DF, Sitrin M. Regulation of vascular smooth muscle contraction. Changes in experimental hypertension. Circ Res 1970;27(Suppl 2):83-90.
5. Heerkens EH, Izzard AS, Heagerty AM. Integrins, vascular remodeling, and hypertension. Hypertension 2007;49:1-4.
6. Weiser MC, Majack RA, Tucker A, Orton EC. Static tension is associated with increased smooth muscle cell DNA synthesis in rat pulmonary arteries. Am J Physiol 1995;268:H1133-1138.
7. Zeidan A, Nordström I, Dreja K, Malmqvist U, Hellstrand P. Stretch-dependent modulation of contractility and growth in smooth muscle of rat portal vein. Circ Res 2000;87:228-234.
8. Lee S, Lee RT. Mechanical stretch and intimal hyperplasia: the missing link? Arterioscler Thromb Vasc Biol 2010;30:459-460.
9. Mahoney WM, Schwartz SM. Defining smooth muscle cells and smooth muscle injury. J Clin Invest 2005;115:221-224.
10. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A et al. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 1999;17: 1099-1107.
11. Lauth M, Wagner AH, Cattaruzza M, Orzechowski HD, Paul M, Hecker M. Transcriptional control of deformation-induced preproendothelin-1 gene expression in endothelial cells. J Mol Med (Berl) 2000;78:441-450.
12. Demicheva E, Hecker M, Korff T. Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis. Circ Res 2008;103:477-484.
13. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997;81:1-7.
14. Parmacek MS. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 2007;100:633-644.
15. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001;105:851-862.
16. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-189.
17. Zhou J, Hu G, Herring BP. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. Mol Cell Biol 2005;25:9874-9885.
18. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci USA 2003;100:9366-9370.
19. Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 1997;81:904-910.
20. Numaguchi K, Eguchi S, Yamakawa T, Motley ED, Inagami T. Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 1999;85:5-11.
21. Albinsson S, Nordström I, Hellstrand P. Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J Biol Chem 2004;279: 34849-34855.
22. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998;35:73-84.
23. Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 2000;102:1186-1191.
24. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000;36:312-318.
25. Long X, Bell RD,GerthofferWT,Zlokovic BV,Miano JM.Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler Thromb Vasc Biol 2008;28:1505-1510.
26. Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS et al. Myocardin inhibits cellular proliferation by inhibiting NF-kB(p65)-dependent cell cycle progression. Proc Natl Acad Sci USA 2008;105:3362-3367.
27. Miano JM, Carlson MJ, Spencer JA, Misra RP. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem 2000;275:9814-9822.
28. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593.
29. Du KL, Ip HS, Li J, Chen M, Dandre F, Yu W et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 2003;23:2425-2437.
30. Yoshida T, Kawai-Kowase K, Owens GK. Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler Thromb Vasc Biol 2004;24:1596-1601.
31. Taurin S, Sandbo N, Yau DM, Sethakorn N, Kach J, Dulin NO. Phosphorylation of myocardin by extracellular signal-regulated kinase. J Biol Chem 2009;284: 33789-33794.
32. Ingram AJ, James L, Cai L, Thai K, Ly H, Scholey JW. NO inhibits stretch-induced MAPK activity by cytoskeletal disruption. J Biol Chem 2000;275:40301-40306.
33. Lehoux S, Esposito B, Merval R, Tedgui A. Differential regulation of vascular focal adhesion kinase by steady stretch and pulsatility. Circulation 2005;111: 643-649.
34. Kawabe J, Okumura S, Lee MC, Sadoshima J, Ishikawa Y. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004;286:H1845-1852.
35. Kawamura S, Miyamoto S, Brown JH. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem 2003;278:31111-31117.
36. Nakamura S, Hayashi K, Iwasaki K, Fujioka T, Egusa H, Yatani H et al. Nuclear import mechanism for myocardin family members and their correlation with vascular smooth muscle cell phenotype. J Biol Chem 2010;285:37314-37323.
37. Xie P, Fan Y, Zhang H, Zhang Y, She M, Gu D et al. CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol 2009;29:2398-2408.
38. Hu G, Wang X, Saunders DN, Henderson M, Russell AJ, Herring BP et al. Modulation of myocardin function by the ubiquitin E3 ligase UBR5. J Biol Chem 2010;285: 11800-11809.
39. Yin H, Jiang Y, Li H, Li J, Gui Y, Zheng XL. Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells. J Cell Physiol 2011;226:1897-1906.
40. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D et al. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003;348: 2609-2617.